When most people hear the word biomarkers, they think of blood work — cholesterol, glucose, inflammatory proteins, or hormone levels.
And while traditional diagnostic biomarkers measured in blood and other body fluids play an important role in medicine — helping doctors diagnose disease, monitor treatment response, and guide therapeutic intervention — they are only part of the picture.
If we care about aging well, we need to measure more than what’s happening at the cellular level. We need to assess how the whole body functions.
That’s where alternative aging biomarkers come in.
These objectively measured indicators — like grip strength, gait speed, body composition, balance tests, and cognitive performance — may offer powerful insight into your biological state, long-term health outcomes, and risk of functional decline.
Let’s explore why these metrics matter — and how to test, benchmark, and optimize them.
What Are Biomarkers, Really?
Image from Tally Health
The National Academy defines biological markers (biomarkers) as characteristics that are objectively measured and evaluated as indicators of:
Normal biological processes
Pathogenic processes
Response to a specific therapy
In clinical trials and drug development, biomarkers are used to:
Detect disease
Monitor progression
Predict treatment effectiveness
Evaluate toxicity
Guide targeted therapies
For example:
High blood pressure is a biomarker for cardiovascular disease risk.
Elevated blood glucose is linked to diabetes.
Certain molecular mutations help diagnose breast cancer and guide cancer treatment.
But not all biomarkers require blood, urine, or molecular detection.
Some of the most powerful prognostic biomarkers for aging are functional.
1. Relative Handgrip Strength (HGS)
Image from Tally Health
Grip strength may be one of the most underrated biomarkers in aging research.
Why Grip Strength Matters
Absolute handgrip strength has long been associated with:
Cardiovascular disease risk
All-cause mortality
Functional decline
Cognitive impairment
But newer biomarker research suggests that relative handgrip strength — calculated as grip strength divided by Body Mass Index (BMI) — may be even more predictive.
This metric adjusts for body size, providing a more meaningful assessment of muscle quality and cardiometabolic health.
Studies show relative HGS is:
A superior predictor of cardiometabolic risk
Linked to diabetes risk
Associated with inflammation levels
Predictive of cognitive outcomes
In many populations, lower grip strength has been consistently linked to higher risk of cardiovascular disease and poorer outcomes in patients with specific diseases.
Why It’s a Powerful Prognostic Biomarker
Unlike many blood-based biomarkers, grip strength reflects:
Neuromuscular integrity
Muscle mass
Central nervous system function
Metabolic health
It integrates multiple systems — making it a whole-body indicator of biological aging. It’s essentially a reflection of musculoskeletal health and capacity.
2. Gait Speed: A Longevity Vital Sign
Image from Tally Health
Gait speed — how fast you walk at your normal pace — is sometimes called a “vital sign” for longevity.
It’s simple to measure:
Time how long it takes to walk a set distance (often 4–6 meters).
Calculate meters per second.
Why Gait Speed Predicts Outcomes
Slower gait speed has been linked to:
Higher mortality risk
Increased risk of cardiovascular disease
Cognitive decline
Lewy body disorders
Functional disability
Gait requires coordination between:
Brain
Muscles
Joints
Cardiovascular system
That means it reflects the integrated health of multiple tissues and systems.
In research settings, gait speed has been evaluated as a prognostic biomarker that can predict disease progression and health outcomes more effectively than some traditional laboratory tests.
3. Body Composition (FFMI and Skeletal Muscle Mass)
Image from Tally Health
When people focus on weight alone, they miss what truly matters: composition.
Two important biological markers include:
Fat-Free Mass Index (FFMI)
Skeletal muscle mass
Why Muscle Mass Matters
Skeletal muscle plays an important role in:
Glucose metabolism
Insulin sensitivity
Energy production
Resting metabolic rate
Inflammation regulation
Low muscle mass is associated with:
Higher risk of diabetes
Increased cardiovascular disease risk
Frailty
Functional decline
In aging research, muscle loss is strongly linked to negative health outcomes.
Importantly, muscle mass often drives improvements in strength metrics like relative handgrip strength.
Unlike many molecular biomarkers measured in blood, muscle mass represents a structural reserve — a protective factor that supports resilience during stress, illness, or recovery from treatment.
4. Resting Metabolic Rate (RMR)
Image from Tally Health
Resting Metabolic Rate measures how many calories your body burns at rest to maintain normal biological processes.
It reflects:
Energy efficiency
Mitochondrial function
Metabolic health
Why RMR Is an Emerging Biomarker
A declining or unusually low RMR may reflect:
Loss of lean mass
Metabolic adaptation
Underlying disease state
Conversely, extremely high levels in certain contexts may reflect hypermetabolic stress or inflammation.
RMR provides insight into the body’s energy demands and metabolic flexibility — offering a systems-level view that complements traditional blood biomarkers like glucose or lipid concentrations.
5. Cognitive Function as a Biomarker
Image from Tally Health
Cognitive testing may act as a functional biomarker of brain health.
Studies show that grip strength — especially when normalized by lean body mass — is a significant predictor of cognitive performance.
Lower strength and slower gait speed have been linked to:
Cognitive decline
Higher risk of dementia
Neurodegenerative conditions including Lewy body disorders
Cognitive function testing assesses:
Processing speed
Executive function
Memory
Reaction time
Rather than detecting molecular changes in cerebrospinal fluid or identifying protein concentrations in blood, these tests measure real-world brain performance.
They provide early detection of subtle changes in biological state before overt disease diagnosis.
6. Functional Movement Metrics
Image from Tally Health
Beyond grip strength and gait speed, additional performance-based biomarkers include:
Vertical jump height
Peak power output
Sit-to-stand tests
Physical performance batteries
These assessments measure:
Neuromuscular coordination
Explosive power
Lower-body strength
Functional capacity
Peak power, in particular, declines earlier than muscle mass alone — making it a sensitive indicator of aging progression.
In some cases, functional performance metrics may predict health outcomes more accurately than isolated molecular biomarkers.
Why Functional Biomarkers Matter
Image from Tally Health
Traditional biomarkers measured in blood, urine, or tissues remain critical for diagnosing specific diseases, detecting cancer, monitoring drug response, and guiding therapy.
But many biomarkers reflect disease after pathogenic processes are already well underway.
Functional biomarkers, on the other hand:
Capture integrated system performance
Reflect real-world capacity
Predict susceptibility to disease
Indicate resilience
They bridge the gap between molecular changes and lived health.
In the context of aging, they may serve as powerful predictive biomarkers — helping researchers and clinicians assess risk long before overt disease develops.
A Broader View of Aging Biomarker Research
Image from Tally Health
Modern biomarker research increasingly recognizes that aging is not just a molecular process — it’s a systems-level phenomenon.
Biological aging affects:
Muscles
Brain
Cardiovascular system
Metabolism
Connective tissues
By measuring strength, movement, metabolic rate, and cognition, we gain insight into how the organism functions as a whole.
These metrics are:
Objectively measured
Non-invasive
Clinically meaningful
Predictive of long-term outcomes
And importantly, they are modifiable through:
Exercise
Nutrition
Diet quality
Targeted therapies
Lifestyle interventions
The Future Aging Assessment
Image from Tally Health
In clinical pharmacology and drug development, biomarkers are essential for evaluating treatment response and safety.
But in longevity science, we must expand our definition of what counts as a meaningful indicator.
Yes, blood pressure matters.Yes, molecular biomarkers and protein concentrations provide valuable diagnostic information.
But so do:
How strong you are
How fast you walk
How much muscle you carry
How efficiently you generate energy
How well your brain performs
Together, these alternative aging biomarkers offer a powerful lens into biological age — not just disease detection.
What are alternative aging biomarkers?
Alternative aging biomarkers are objectively measured functional indicators — such as grip strength, gait speed, body composition, balance tests, and cognitive performance — that offer insight into your biological state, long-term health outcomes, and risk of functional decline.
Why is grip strength considered a powerful aging biomarker?
Grip strength reflects neuromuscular integrity, muscle mass, central nervous system function, and metabolic health, making it a whole-body indicator of biological aging. Relative handgrip strength — grip strength divided by BMI — is considered especially predictive of cardiometabolic risk, diabetes, inflammation, and cognitive outcomes.
How is gait speed measured and why does it matter?
Gait speed is measured by timing how long it takes to walk a set distance (often 4–6 meters) and calculating meters per second. It is considered a longevity "vital sign" because walking requires coordination between the brain, muscles, joints, and cardiovascular system, making it a reliable predictor of mortality, cognitive decline, and functional disability.
References
Perri et al. An Expert Consensus Statement on Biomarkers of Aging for Use in Intervention Studies. J Gerontol Biol Sci Med Sci 2025; https://doi.org/10.1093/gerona/glae297
Moqri et al. Validation of biomarkers of aging. Nat Med 2024; https://doi.org/10.1038/s41591-023-02784-9
Bao et al. Biomarkers of aging. Sci China Life Sci 2023; https://doi.org/10.1007/s11427-023-2305-0
Baker and Sprott. Biomarkers of aging. Exp Gerontol 1988; https://doi.org/10.1016/0531-5565(88)90025-3
Johnson and Shokhirev. Contextualizing aging clocks and properly describing biological age. Aging Cell 2024; https://doi.org/10.1111/acel.14377
